Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 389

The DOI matches its Crossref record.

Five Hundred Intestinal and Multivisceral Transplantations at a Single Center: Major Advances With New Challenges

Abu-Elmagd, Kareem M., Costa, Guilherme, Bond, Geoffrey J., Soltys, Kyle, Sindhi, Rakesh, Wu, Tong, Koritsky, Darlene A., Schuster, Bonita, Martin, Lillian, Cruz, Ruy J., Murase, Noriko, Zeevi, Adriana, Irish, William, Ayyash, Maher O., Matarese, Laura, Humar, Abhinav, Mazariegos, George·2009·Annals of Surgery

Abstract

OBJECTIVE: To assess the evolution of visceral transplantation in the milieu of surgical technical modifications, new immunosuppressive protocols, and other management strategies. SUMMARY BACKGROUND DATA: With the clinical feasibility of intestinal and multivisceral transplantation in 1990, multifaceted innovative tactics were required to improve outcome and increase procedural practicality. METHODS: Divided into 3 eras, 453 patients received 500 visceral transplants. The primary used immunosuppression was tacrolimus-steroid-only during Era I (5/90–5/94), adjunct induction with multiple drug therapy during Era II (1/95–6/01), and recipient pretreatment with tacrolimus monotherapy during Era III (7/01–11/08). During Era II/III, donor bone marrow was given (n = 79), intestine was ex vivo irradiated (n = 44), and Epstein-Barr-Virus (EBV)/cytomegalovirus (CMV) loads were monitored. RESULTS: Actuarial patient survival was 85% at 1-year, 61% at 5-years, 42% at 10-years, and 35% at 15-years with respective graft survival of 80%, 50%, 33%, and 29%. With a 10% retransplantation rate, second/third graft survival was 69% at 1-year and 47% at 5-years. The best outcome was with intestine-liver allografts. Era III rabbit antithymocyte globulin or alemtuzumab pretreatment-based strategy was associated with significant (P < 0.0001) improvement in outcome with 1- and 5-year patient survival of 92% and 70%. CONCLUSION: Survival has greatly improved over time as management strategies evolved. The current results clearly justify elevating the procedure level to that of other abdominal organs with the privilege to permanently reside in a respected place in the surgical armamentarium. Meanwhile, innovative tactics are still required to conquer long-term hazards of chronic rejection of liver-free allografts and infection of multivisceral recipients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e3181b67725

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 389

Metadata

Authors
Abu-Elmagd, K. M., Costa, G., Bond, G. J., Soltys, K., Sindhi, R., Wu, T., Koritsky, D. A., Schuster, B., Martin, L., Cruz, R. J., Murase, N., Zeevi, A., Irish, W., Ayyash, M. O., Matarese, L., Humar, A., & Mazariegos, G.
Venue
Annals of Surgery
Published
2009-10
Volume
250
Issue
4
Pages
567-581
ISSN
0003-4932
OpenAlex
W2083256666
Cited by
389
References
0
FWCI
22.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Five Hundred Intestinal and Multivisceral Transplantations at a Single Center: Major Advances With New Challenges. https://app.cochat.ai/papers/10.1097/sla.0b013e3181b67725
The paper
Abu-Elmagd, K. M., Costa, G., Bond, G. J., Soltys, K., Sindhi, R., Wu, T., Koritsky, D. A., Schuster, B., Martin, L., Cruz, R. J., Murase, N., Zeevi, A., Irish, W., Ayyash, M. O., Matarese, L., Humar, A., & Mazariegos, G. (2009). Five Hundred Intestinal and Multivisceral Transplantations at a Single Center: Major Advances With New Challenges. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181b67725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.